Top
image credit: Pixabay

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

September 1, 2022

Category:

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain.

COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some. Massoumi says Dr. B allows patients to receive the drugs promptly, without an in-person office visit, and, at times, at no cost.

Read More on Pharmaphorum